Objective: To examine the prevalence of suboptimal medication-related processes of care before the hospitalisation of older patients.
Design and setting: We conducted a retrospective cohort study using a clinical indicator set related to medication management that has been validated by an expert panel as consisting of suboptimal aspects of medication use that clinicians should be able to foresee and avoid. Australian Government Department of Veterans’ Affairs administrative claims data between 1 July 2007 and 30 June 2012 were analysed according to these clinical indicators to assess medication-related processes of care preceding hospitalisation.
Participants: Veterans with one or more hospitalisations in Australia for a condition defined by the clinical indicator set.
Main outcome measure: Prevalence of suboptimal medication-related processes of care before hospitalisation as a proportion of all hospitalisations defined by diagnoses in the clinical indicator set.
Results: During the 5-year study period, there were 164 813 hospitalisations with primary diagnoses for conditions included in the clinical indicator set, encompassing 83 430 patients. The overall proportion of hospitalisations that were preceded by suboptimal medication-related processes of care was 25.2% (41 546 hospitalisations); 34.5% of patients (28 807 patients) had at least one hospitalisation and 10.4% (8640 patients) had two or more hospitalisations preceded by suboptimal medication-related processes of care. At least one in 10 hospitalisations for chronic heart failure, ischaemic stroke, asthma, gastrointestinal ulcer or bleeding, fracture, renal failure or nephropathy, hyperglycaemia or hypoglycaemia were preceded by suboptimal medication-related processes of care.
Conclusions: This study highlights conditions for which there are evidence–practice gaps in medication management in the older population. Routine prospective monitoring of these evidence-based, validated, medication-related clinical indicators provides a means for quality improvement in the management of common chronic conditions.
- 1. Australian Institute of Health and Welfare. Chronic diseases and associated risk factors in Australia, 2006. Canberra: AIHW, 2006. (AIHW Cat. No. PHE 81.) http://www.aihw.gov.au/publication-detail/?id=6442467914 (accessed Apr 2014).
- 2. Australian Institute of Health and Welfare. Health expenditure Australia, 2010-11. Health and welfare expenditure series no. 47. Canberra: AIHW, 2012. (AIHW Cat. No. HWE56.) http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737423003 (accessed Apr 2014).
- 3. Roughead L, Semple S, Rosenfeld E. Literature review: medication safety in Australia. Sydney: Australian Commission on Safety and Quality in Health Care, 2013. http://www.safetyandquality.gov.au/wp-content/uploads/2013/08/Literature-Review-Medication-Safety-in-Australia-2013.pdf (accessed Mar 2013).
- 4. Australian Institute of Health and Welfare. Australian hospital statistics 2011-12. Health services series no. 50. Canberra: AIHW, 2013. (AIHW Cat. No. HSE 134.) http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129543146 (accessed Jun 2014).
- 5. Robertson H, MacKinnon N. Development of a list of consensusapproved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002; 24: 1595-1613.
- 6. Morris CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity — determining valid indicators. Int J Qual Health Care 2002; 14: 183-198.
- 7. Mackinnon NJ, Hepler CD. Indicators of preventable drug-related morbidity in older adults 2. Use within a managed care organization. J Manag Care Pharm 2003; 9: 134-141.
- 8. Sauer B, Hepler CD, Cherney B, Williamson J. Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care 2007; 13: 29-35.
- 9. Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable medication-related hospitalisations in Australia: an opportunity to reduce harm. Int J Qual Health Care 2012; 24: 239-249.
- 10. Mainz J. Quality indicators: essential for quality improvement. Int J Qual Health Care 2004; 16(s1): i1-i2.
- 11. Caughey GE, Kalisch Ellett LM, Wong TY. Development of evidence based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method. BMJ Open 2014; 4: e004625.
- 12. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-543.
- 13. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2015. http://www.whocc.no/atc_ddd_index/ (accessed Jun 2015).
- 14. Australian Government Department of Health. Pharmaceutical Benefits Scheme (PBS). 2015. http://www.pbs.gov.au/pbs/home (accessed Apr 2015).
- 15. Australian Government Department of Health and Ageing. The December 2012 Medicare Benefits Schedule. Canberra: Department of Health and Ageing, 2012. http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-201212 (accessed Jan 2013).
- 16. Australian Consortium for Classification Development. ICD-10-AM/ACHI/ACS. Sydney: National Centre for Classification in Health, 2015. https://www.accd.net.au/Icd10.aspx (accessed Jun 2015).
- 17. Runciman WB, Hunt TD, Hannaford NA, et al. CareTrack: assessing the appropriateness of health care delivery in Australia. Med J Aust 2012; 197: 100-105. <MJA full text>
- 18. Australian Institute of Health and Welfare. National Health Priority Areas. Canberra: AIHW, 2012. http://www.aihw.gov.au/national-health-priority-areas/ (accessed Jun 2012).
- 19. Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-192. <MJA full text>
- 20. Roughead EE, Barratt JD, Ramsay EN, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalisation for heart failure patients in the practice setting: results of a cohort study. Cir Heart Fail 2009; 2: 424-428.
- 21. Roughead EE, Barratt JD, Ramsay EN, et al. Collaborative home medicines review delays time to next hospitalisation for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther 2011; 36: 27-32.
- 22. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated October 2011. http://www.heartfoundation.org.au/SiteCollectionDocuments/Chronic_Heart_Failure_Guidelines_2011.pdf (accessed Apr 2012).
- 23. Australian Institute of Health and Welfare. Health care usage and costs. A comparison of veterans and war widows and widowers with the rest of the community. Canberra: AIHW, 2002. (AIHW Cat. No. PHE42.) http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442459409 (accessed Jun 2014).
- 24. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62: 1172-1181.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.